Cranbrook Wealth Management, LLC
Source: SEC Form 13F · as of Mar 2026Cranbrook Wealth Management, LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $7.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$7.2M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 14,683 | $3.2M |
| ABTABBOTT LABORATORIES | 11,417 | $1.2M |
| JNJJOHNSON & JOHNSON | 4,440 | $1.1M |
| MRKMerck & Co., Inc. | 4,475 | $538K |
| IDXXIDEXX LABORATORIES INC /DE | 611 | $343K |
| LLYELI LILLY & Co | 287 | $264K |
| PMPhilip Morris International Inc | 1,165 | $193K |
| BMYBRISTOL MYERS SQUIBB CO | 2,136 | $130K |
| PFEPFIZER INC | 4,512 | $127K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 508 | $28K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 1,313 | $24K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 87 | $24K |
| BAXBaxter International Inc. | 658 | $11K |
| ZTSZoetis Inc. | 93 | $11K |
| VTRSViatris Inc | 508 | $7K |
| NEOGNEOGEN CORP | 134 | $1K |
| OGNOrganon & Co. | 169 | $1K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.